日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱(chēng) 貨號(hào) 規(guī)格
Recombinant Methanopyrus kandleri Proteasome subunit alpha (psmA) CSB-YP823593MSI
CSB-EP823593MSI
CSB-BP823593MSI
CSB-MP823593MSI
CSB-EP823593MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri ATP phosphoribosyltransferase (hisG) CSB-YP823594MSI
CSB-EP823594MSI
CSB-BP823594MSI
CSB-MP823594MSI
CSB-EP823594MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP823595MSI
CSB-EP823595MSI
CSB-BP823595MSI
CSB-MP823595MSI
CSB-EP823595MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri 30S ribosomal protein S10P (rps10p) CSB-YP823596MSI
CSB-EP823596MSI
CSB-BP823596MSI
CSB-MP823596MSI
CSB-EP823596MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri tRNA (guanine (26)-N (2))-dimethyltransferase (trm1) CSB-YP823597MSI
CSB-EP823597MSI
CSB-BP823597MSI
CSB-MP823597MSI
CSB-EP823597MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri Serine hydroxymethyltransferase (glyA) CSB-YP823598MSI
CSB-EP823598MSI
CSB-BP823598MSI
CSB-MP823598MSI
CSB-EP823598MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri Quinolinate synthase A (nadA) CSB-YP823599MSI
CSB-EP823599MSI
CSB-BP823599MSI
CSB-MP823599MSI
CSB-EP823599MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanopyrus kandleri Cytidylate kinase (cmk) CSB-YP823600MSI
CSB-EP823600MSI
CSB-BP823600MSI
CSB-MP823600MSI
CSB-EP823600MSI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L37Ae (rpl37ae) CSB-YP823601FHW
CSB-EP823601FHW
CSB-BP823601FHW
CSB-MP823601FHW
CSB-EP823601FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L11P (rpl11p) CSB-YP823602FHW
CSB-EP823602FHW
CSB-BP823602FHW
CSB-MP823602FHW
CSB-EP823602FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Phosphoenolpyruvate carboxylase (ppcA) CSB-YP823603FHW
CSB-EP823603FHW
CSB-BP823603FHW
CSB-MP823603FHW
CSB-EP823603FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Signal recognition particle 19 kDa protein (srp19) CSB-YP823604FHW
CSB-EP823604FHW
CSB-BP823604FHW
CSB-MP823604FHW
CSB-EP823604FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Lysyl aminopeptidase (PF1861) CSB-YP823605FHW
CSB-EP823605FHW
CSB-BP823605FHW
CSB-MP823605FHW
CSB-EP823605FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L23P (rpl23p) CSB-YP823606FHW
CSB-EP823606FHW
CSB-BP823606FHW
CSB-MP823606FHW
CSB-EP823606FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 50S ribosomal protein L5P (rpl5p) CSB-YP823607FHW
CSB-EP823607FHW
CSB-BP823607FHW
CSB-MP823607FHW
CSB-EP823607FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 30S ribosomal protein S5P (rps5p) CSB-YP823608FHW
CSB-EP823608FHW
CSB-BP823608FHW
CSB-MP823608FHW
CSB-EP823608FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus UPF0173 metal-dependent hydrolase PF1764 (PF1764) CSB-YP823609FHW
CSB-EP823609FHW
CSB-BP823609FHW
CSB-MP823609FHW
CSB-EP823609FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus UPF0292 protein PF1724 (PF1724) CSB-YP823610FHW
CSB-EP823610FHW
CSB-BP823610FHW
CSB-MP823610FHW
CSB-EP823610FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus Acetyl-lysine deacetylase (lysK) CSB-YP823611FHW
CSB-EP823611FHW
CSB-BP823611FHW
CSB-MP823611FHW
CSB-EP823611FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus furiosus 30S ribosomal protein S11P (rps11p) CSB-YP823612FHW
CSB-EP823612FHW
CSB-BP823612FHW
CSB-MP823612FHW
CSB-EP823612FHW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×